ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (22)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blomberg, A.
Right arrow Articles by Bernard, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blomberg, A.
Right arrow Articles by Bernard, A.
Eur Respir J 2003; 22:883-888
Copyright ©ERS Journals Ltd 2003


Clara cell protein as a biomarker for ozone-induced lung injury in humans

A. Blomberg1, I. Mudway2, M. Svensson3, A. Hagenbjörk-Gustafsson4, L. Thomasson4, R. Helleday1, X. Dumont5, B. Forsberg3, G. Nordberg3 and A. Bernard5

1 Dept of Respiratory Medicine and Allergy, University Hospital, 3 Environmental and Occupational Medicine, Dept of Public Health and Clinical Medicine, Umeå University, and 4 National Institute for Working Life, Umeå, Sweden. 2 School of Health and Life Sciences, King's College London, London, UK. 5 Industrial Toxicology Unit, Faculty of Medicine, Catholic University of Louvain, Brussels, Belgium.

CORRESPONDENCE: A. Blomberg, Dept of Respiratory Medicine and Allergy, University Hospital, SE-901 85, Umeå, Sweden. Fax: 46 90141369. E-mail: anders.blomberg@lung.umu.se

Keywords: air pollution, biomarkers, Clara cell protein, lung permeability, ozone

Received: May 1, 2003
Accepted July 16, 2003

This study was supported by the European Commission HELIOS project (QLK4CT-1999-01308), the Swedish Heart-Lung Foundation, Umeå University, the Swedish Environmental Protection Agency and the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS), Sweden.

Exposure to ozone (O3) impairs lung function, induces airway inflammation and alters epithelial permeability. Whilst impaired lung function and neutrophilia have been observed at relatively low concentrations, altered lung epithelial permeability is only seen after high-dose challenges. The appearance of Clara cell protein (CC16) in serum has been proposed as a sensitive marker of lung epithelial injury. Here, the use of CC16 as an injury biomarker was evaluated under a controlled exposure to O3 and the relationship between this marker of lung injury and early lung function decrements was investigated.

Subjects (n=22) were exposed on two separate occasions to 0.2 parts per million O3 and filtered air for 2 h. Blood samples were drawn and lung function assessed at 2 h pre-exposure, immediately before and immediately after exposure as well as 2 and 4 h postexposure.

O3 increased CC16 serum concentrations at 2 h (12.0±4.5 versus 8.4±3.1 µg·L–1) and 4 h postexposure (11.7±5.0 versus 7.9±2.6 µg·L–1) compared with air concentrations. Archived samples from O3 studies utilising the same design indicated that this increase was sustained for up to 6 h postexposure (9.1±2.6 versus 7.1±1.7 µg·L–1) with concentrations returning to baseline by 18 h (7.7±2.9 versus 6.6±1.7 µg·L–1). In these studies, the increased plasma CC16 concentration was noted in the absence of increases in traditional markers of epithelial permeability. No association was observed between increased CC16 concentrations and lung function changes.

To conclude, Clara cell protein represents a sensitive and noninvasive biomarker for ozone-induced lung epithelial damage that may have important uses in assessing the health effects of air pollutants in future epidemiological and field studies.




This article has been cited by other articles:


Home page
ChestHome page
J. A. Kropski, R. D. Fremont, C. S. Calfee, and L. B. Ware
Clara Cell Protein (CC16), a Marker of Lung Epithelial Injury, Is Decreased in Plasma and Pulmonary Edema Fluid From Patients With Acute Lung Injury
Chest, June 1, 2009; 135(6): 1440 - 1447.
[Abstract] [Full Text] [PDF]


Home page
Occup. Environ. Med.Home page
L Barregard, G Sallsten, L Andersson, A-C Almstrand, P Gustafson, M Andersson, and A-C Olin
Experimental exposure to wood smoke: effects on airway inflammation and oxidative stress
Occup. Environ. Med., May 1, 2008; 65(5): 319 - 324.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
I. Romieu, F. Castro-Giner, N. Kunzli, and J. Sunyer
Air pollution, oxidative stress and dietary supplementation: a review
Eur. Respir. J., January 1, 2008; 31(1): 179 - 197.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. T. Coppens, L. S. Van Winkle, K. Pinkerton, and C. G. Plopper
Distribution of Clara cell secretory protein expression in the tracheobronchial airways of rhesus monkeys
Am J Physiol Lung Cell Mol Physiol, May 1, 2007; 292(5): L1155 - L1162.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. Chen, S. Lam, A. Pilon, A. McWilliams, J. Melby, and E. Szabo
The Association between the Anti-inflammatory Protein CC10 and Smoking Status among Participants in a Chemoprevention Trial
Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 577 - 583.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. Helleday, B. Segerstedt, B. Forsberg, I. Mudway, G. Nordberg, A. Bernard, and A. Blomberg
Exploring the time dependence of serum clara cell protein as a biomarker of pulmonary injury in humans.
Chest, September 1, 2006; 130(3): 672 - 675.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the European Respiratory Society.